{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:02:58Z","timestamp":1795104178549,"version":"4.10.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijantimicag.2024.107151","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:43:59Z","timestamp":1710816239000},"page":"107151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-9560","authenticated-orcid":false,"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijantimicag.2024.107151_bib0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPG.0000000000002036","article-title":"Management of paediatric ulcerative colitis, part 2: acute severe colitis-an evidence-based consensus guideline from the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/FTD.0000000000000282","article-title":"Relationship of sulfamethoxazole therapeutic drug monitoring to clinical efficacy and toxicity: a retrospective cohort study","volume":"38","author":"Ice","year":"2016","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107151_bib0003","doi-asserted-by":"crossref","first-page":"e13609","DOI":"10.1111\/petr.13609","article-title":"Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers","volume":"24","author":"Paulsen","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1016\/j.ijantimicag.2024.107151_bib0004","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jirovecii in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0005","first-page":"663","article-title":"Renal impairment associated with trimethoprim-sulfamethoxazole use in the pediatric population","volume":"27","author":"Sierra","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0006","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jiac.2016.01.019","article-title":"Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 \u03bcg\/mL serum trough concentration","volume":"22","author":"Kato","year":"2016","journal-title":"J Infect Chemother"},{"issue":"9","key":"10.1016\/j.ijantimicag.2024.107151_bib0007","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1060028020909539","article-title":"Dose-dependent hyperkalemia among hospitalized, HIV-infected patients receiving sulfamethoxazole\/trimethoprim","volume":"54","author":"Caulder","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.ijantimicag.2024.107151_bib0008","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines","volume":"158","author":"Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000089682","article-title":"Effect of trimethoprim-sulfamethoxazole on Na and K+ transport properties in the rabbit cortical collecting duct perfused in vitro","volume":"102","author":"Muto","year":"2006","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0010","first-page":"43","article-title":"Trastubular potassium concentration gradient inpremature neonates and full-term neonates","volume":"14","author":"Kawasaki","year":"2000","journal-title":"Jpn J Pediatr Nephrl"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3476(78)80133-4","article-title":"Developmental patterns of renal functional maturation compared in the human neonate","volume":"92","author":"Arant","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/clinids\/4.2.429","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole","volume":"4","author":"Lawson","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0013","article-title":"Multicenter study of trimethoprim\/sulfamethoxazole related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0014","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516993","article-title":"Acetylator status and tolerance of high dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus","volume":"25","author":"Smith","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00008571-199712000-00009","article-title":"Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations","volume":"7","author":"Xie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2362.33.s2.6.x","article-title":"Clinical relevance of genetic polymorphisms in the human CYP2C9 gene","volume":"33","author":"Schwarz","year":"2003","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0017","first-page":"379","article-title":"Human cytochrome P450 maximal activities in pediatric versus adult liver","volume":"28","author":"Blanco","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0018","doi-asserted-by":"crossref","first-page":"k341","DOI":"10.1136\/bmj.k341","article-title":"Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study","volume":"360","author":"Crellin","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijantimicag.2024.107151_bib0019","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2215\/CJN.08110910","article-title":"Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children","volume":"6","author":"Moffett","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2024.107151_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/FTD.0000000000000128","article-title":"Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes","volume":"37","author":"Yamamoto","year":"2015","journal-title":"Ther Drug Monit"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T06:28:22Z","timestamp":1714285702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0924857924000694"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107151","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107151"}}